Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report

Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report

Atypical hemolytic uremic syndrome (aHUS), also called complement-mediated hemolytic uremic syndrome (CM-HUS), is a rare disease caused by dysregulation in the alternative complement activation pathway. It is a life-threatening condition causing ischemia of a number of organs, and it typically cause...

Full description

Bibliographic Details
Main Authors: Romana Rysava, Martina Peiskerova, Vladimir Tesar, Jan Benes, Martin Kment, Ágnes Szilágyi, Dorottya Csuka, Zoltán Prohászka
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
atypical hemolytic uremic syndrome
thrombotic microangiopathies
acute kidney injury
mRNA vaccine against SARS-CoV-2
complement
genetic risk
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001366/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001366/full

Similar Items